DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Swisher EM, Lin KK, Oza AM. et al.
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
Lancet Oncol 2017;
18: 75-87
doi:10.1016/S1470-2045(16)30559-9
We do not assume any responsibility for the contents of the web pages of other providers.